# US 2017/0290513 A1 · Ingestible event marker data framework

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0290513 A1
- Document ID: US20170290513A1
- Status: Published application
- Kind: A1
- Application number: 15/498,396
- Filed: 2017-04-26
- Published: 2017-10-12
- Earliest claimed: 2008-07-08
- Assignees: Otsuka Pharmaceutical Co., Ltd.
- Applicants: Proteus Digital Health, Inc.
- Inventors: David O'Reilly; Erika Karplus; Andrew Thompson; George Savage; Mark Zdeblick; Timothy Robertson; Lawrence Arne; Yahar Behzadi; Gregory Moon; Patrick Beaulieu
- Web page: https://patentgrep.com/patent/US20170290513A1

## CPC

- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/07: Endoradiosondes
- A61B 5/117: Identification of persons (methods or arrangements for recognising patterns, e.g. fingerprints, G06F18/00, G06V40/00; identification of persons by analysing their voice or speech G10L17/00)
- A61B 5/4833: {Assessment of subject's compliance to treatment}
- G16H 10/65: stored on portable record carriers, e.g. on smartcards, RFID tags or CD
- G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- G16H 80/00: ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- A61B 5/021: Measuring pressure in heart or blood vessels
- G06Q 10/40: Business processes related to social networking or social networking services
- G16H 40/67: for remote operation
- G16Y 20/40: relating to personal data, e.g. biometric data, records or preferences
- G16Y 40/10: Detection; Monitoring
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G16Y: INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]

## Abstract

The ingestible event marker data framework provides a uniform, comprehensive framework to enable various functions and utilities related to ingestible event marker data (IEM data). The functions and utilities include data and/or information having an aspect of data derived from, collected by, aggregated by, or otherwise associated with, an ingestion event.

## Claims

### Claim at position 1

1-26. (canceled)

### Claim 27

A compliance system, comprising:
an ingestible event marker (IEM) device configured to:
generate IEM data after ingestion by an individual, wherein the IEM data comprises first physiologic data associated with the individual; and
transmit a signal comprising the IEM data through the body of the individual; and
a receiver associated with the individual, wherein the receiver is configured to:
receive the signal comprising the IEM data from the IEM device;
measure second physiologic data associated with the individual, wherein at least a portion of the first physiologic data is comparable to at least a portion of the second physiologic data to verify that the individual has ingested the IEM device.

### Claim 28 (depends on 27)

The compliance system of claim 27, wherein the first physiologic data and the second physiologic data are associated with a same physiologic parameter.

### Claim 29 (depends on 28)

The compliance system of claim 28, wherein the physiologic parameter comprises at least one of a heart rate variability, a breathing rate, or a heart rate pattern associated with the individual.

### Claim 30 (depends on 29)

The compliance system of claim 29, wherein the heart rate pattern comprises an ECG pattern.

### Claim 31 (depends on 27)

The compliance system of claim 27, wherein the IEM device comprises an IEM integrated with a medication, and wherein the at least a portion of the first physiologic data is comparable to the at least a portion of the second physiologic data to verify that the individual has ingested the medication.

### Claim 32 (depends on 27)

The compliance system of claim 27, wherein the first physiologic data is measured by the IEM device in temporal proximity to a time of ingestion of the IEM device.

### Claim 33 (depends on 27)

The compliance system of claim 27, wherein the IEM device is configured to wirelessly transmit the signal to the receiver.

### Claim 34 (depends on 27)

The compliance system of claim 27, wherein the IEM device comprises an IEM storing a unique identifier, wherein the unique identifier comprises a data sample reflecting a physiologic pattern associated with the individual, and wherein the IEM data transmitted to the receiver comprises the unique identifier.

### Claim 35 (depends on 34)

The compliance system of claim 34, wherein the data sample comprises at least one of a data sample reflecting a heart rate variability of the individual, a data sample reflecting a breathing rate of the individual, or a data sample reflecting a heart rate pattern of the individual.

### Claim 36 (depends on 35)

The compliance system of claim 35, wherein the data sample reflecting the heart rate pattern of the individual comprises an ECG pattern.

### Claim 37 (depends on 34)

The compliance system of claim 34, wherein the receiver is further configured to:
generate a physiologic identifier for the individual based on the second physiologic data; and
compare the unique identifier received from the IEM device to the generated physiologic identifier to verify that the individual associated with the physiologic pattern has ingested the IEM device.

### Claim 38 (depends on 37)

The compliance system of claim 37, wherein the IEM device comprises an IEM integrated with a medication, and wherein the receiver is configured to compare the unique identifier to the physiologic identifier to verify to verify that the individual has ingested the medication.

### Claim 39 (depends on 34)

The compliance system of claim 34, further comprising:
a data source device associated with the body of the individual, wherein the data source device is configured to generate at least one actual data sample of a physiologic pattern from the individual, and wherein the receiver is further configured to receive the at least one actual data sample from the data source device; and
an IEM system in communication with the receiver, wherein the IEM system is configured to:
receive the at least one actual data sample and the unique identifier from the receiver; and
compare the at least one actual data sample to the unique identifier to verify that the IEM device was actually ingested by the individual.

### Claim 40 (depends on 27)

The compliance system of claim 27, wherein the receiver comprises a personal signal receiver external to the body of the individual.

### Claim 41

A compliance system, comprising:
an ingestible event marker (IEM) device configured to:
generate IEM data after ingestion by an individual, wherein the IEM data comprises first physiologic data associated with the individual; and
transmit a first signal comprising the IEM data through the body of the individual;
a data source device associated with the body of the individual, wherein the data source device is configured to:
generate second physiologic data associated with the individual; and
transmit a second signal comprising the second physiologic data; and
a receiver associated with the individual, wherein the receiver is configured to receive the first signal from the IEM device and the second signal from the data source device.

### Claim 42 (depends on 41)

The compliance system of claim 41, wherein the first physiologic data and the second physiologic data are associated with a same physiologic parameter.

### Claim 43 (depends on 42)

The compliance system of claim 42, wherein the physiologic parameter comprises at least one of a heart rate variability, a breathing rate, or an ECG pattern associated with the individual.

### Claim 44

A method of monitoring compliance, comprising:
transmitting a first signal from an ingestible event marker (IEM) device through the body of an individual, wherein the first signal comprises IEM data generated by the IEM device after ingestion by the individual, and wherein the IEM data comprises first physiologic data associated with the individual;
transmitting a second signal from a data source device associated with the body of the individual, wherein the second signal comprises second physiologic data associated with the individual; and
receiving the first signal and the second signal by a receiver associated with the individual.

### Claim 45 (depends on 44)

The method of claim 44, wherein the first physiologic data and the second physiologic data are associated with the same physiological parameter, wherein the physiologic parameter comprises at least one of a heart rate variability, a breathing rate, or an ECG pattern associated with the individual.

### Claim 46 (depends on 44)

The method of claim 44, further comprising:
comparing at least a portion of the data from the first signal to at least a portion of the data from the second signal to verify that the individual has ingested the IEM device.
